REPEAT: AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce that due to overwhelming interest, the Company’s previously announced June 25Delta Greenhouse Complex Institutional Investor, Industry Analyst and Media Tour (the “Tour”) has been fully subscribed and a formal waitlist has been effected.

AgraFlora Organics Reviews Vertically Integrated Asset Portfolio

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide the following corporate updates pertaining to the Company’s vertically integrated cannabis (“THC”) and cannabidiol (“CBD”) asset portfolio.

/R E P E A T — AgraFlora Organics Provides Q3 2019 – Q4 2020 Guidance for ACMPR Licensed AAA Heidelberg Facility/

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide the following Q3 2019 – Q4 2020 operating guidance pertaining to its wholly owned AAA Heidelberg Facility (“AAA Heidelberg”) including:

REPEAT – AgraFlora Closes Acquisition of Organic Flower’s Downstream and Product Formulation Asset Portfolio

Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or “OFIG” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of its downstream and product formulation portfolio (the “Assets”) to AgraFlora Organics International Inc. (CSE: AGRA) (FWB: PU31) (OTCPK: PUFXF) (“AgraFlora”). Pursuant to the terms of an executed Asset Purchase and Sale Agreement (the “Agreement”), this transaction reunites 70 per cent of Agraflora’s joint venture entity, Propagation Services Canada’s (“PSC”) 2,200,000 square foot Delta Greenhouse Complex under a consolidated corporate umbrella.

/R E P E A T — AgraFlora Closes Acquisition of Organic Flower’s Downstream and Product Formulation Asset Portfolio/

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce it has completed a transaction relating to the acquisition of downstream and product formulation portfolio (the “Assets”) from Organic Flower Investments Group Inc. (CSE: SOW) (FWB: 2K6) (OTC: QILFF) (“Organic Flower” or “OFIG”). Pursuant to the terms of an executed Asset Purchase and Sale Agreement (the “Agreement”), this transaction reunites 70 percent of AgraFlora’s joint venture entity, Propagation Services Canada’s (“PSC¨) 2,200,000 square foot Delta Greenhouse Complex under a consolidated corporate umbrella.

AgraFlora Closes Acquisition of Organic Flower’s Downstream and Product Formulation Asset Portfolio

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce it has completed a transaction relating to the acquisition of downstream and product formulation portfolio (the “Assets”) from Organic Flower Investments Group Inc. (CSE: SOW) (FWB: 2K6) (OTC: QILFF) (“Organic Flower” or “OFIG”). Pursuant to the terms of an executed Asset Purchase and Sale Agreement (the “Agreement”), this transaction reunites 70 percent of AgraFlora’s joint venture entity, Propagation Services Canada’s (“PSC¨) 2,200,000 square foot Delta Greenhouse Complex under a consolidated corporate umbrella.

/R E P E A T — AgraFlora Organics to Sell Colombian Pharmacy to ICC International Cannabis Corp./

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce that it has entered into a binding Letter of Intent (the “Agreement”) with ICC International Cannabis Corp. (“ICC”) (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF), for the strategic sale of its Colombian pharmacy operation, Farma Swiss S.A.S. (“Farma Swiss”).

AgraFlora to Acquire Organic Flower’s Assets; Reunites 2.2M sq.ft. Delta Facility, to Add Portfolio of Turnkey Domestic/International Downstream Assets

Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or “OFIG” or the “Company”) and AgraFlora Organics International Inc. (CSE: AGRA) (FWB: PU31) (OTCPK: PUFXF) (“AgraFlora”) are pleased to announce that Organic Flower and AgraFlora have entered into a binding Letter of Intent (“LOI”) whereby Organic Flower shall sell and AgraFlora shall purchase 100 per cent of Organic Flower’s assets, which includes: the Company’s 20% interest in the Delta Greenhouse Complex, an array of domestic downstream/product formulation operations and the rights to an trans-European distribution network(the “Proposed Transaction”).

Consumers Remain Captivated by Cannabis’ Therapeutic Elements

In 2014, the United Nations World Drug report highlighted that 183 million people consumed cannabis, representing 3.8% of the world’s population. Moreover, it was also reported that 129 countries cultivated cannabis for either medical or recreational purposes. The report noted that while cannabis is one of the most widely consumed drugs, it also faces the strictest regulations. Under the Single Convention on Narcotic Drugs, cannabis is classified as a Schedule 1 drug. International regulatory bodies have deemed cannabis as a dangerous drug largely because of its psychoactive effects, which are derived from its THC compound. However, after extensive clinical trials, researchers have discovered that, in fact, cannabis offers consumers therapeutic benefits as well. The cannabinoids within the cannabis plant have even been linked to effectively treating medical conditions such as chronic pain, cancer, Alzheimer’s, and Parkinson’s. As a result, the Single Convention highlighted the importance of medical cannabis. On the other hand, it discredited the recreational market. Despite the regulations under the Single Convention, the recreational market still remains prosperous in the North American region. Specifically, the U.S. accounts for a majority of the global market share because a handful of states adopted favourable legislation early on. Not to be cast aside, Canada is also positioned to become a major market as its recreational market continues to mature after its country-wide legalization. According to data compiled by Ameri Research, the global legal marijuana market was valued at USD 14.3 Billion in 2016. By 2024, legal marijuana global sales are projected to reach USD 63.5 Billion while exhibiting a CAGR of 21.1% from 2017 to 2024. AREV Brands International Ltd. (OTC: AREVF) (CSE: AREV), iAnthus Capital Holdings, Inc. (OTC: ITHUF) (CSE: IAN), The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX-V: WTER), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH), AgraFlora Organics International Inc. (OTC: PUFXF) (CSE: AGRA)